Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
4940 Results Found
HHS to stop funding mRNA vaccine development under BARDA
The Department of Health and Human Services Aug. 7 announced it will no longer fund mRNA vaccine development under the Biomedical Advanced Research and Development Authority.
Analysis finds ACA plans seek to more than double last year’s median proposed premium increase
A new analysis published Aug. 6 by the Peterson Center on Healthcare and KFF found that Health Insurance Marketplace insurers will propose a median premium increase of 18% for 2026.
New CDC campaign addresses youth substance use, mental health
The Centers for Disease Control and Prevention Aug. 5 announced a new campaign educating youth ages 12-17 on substance use, mental health and how they are connected.
AHA to host new Healthier Together Conference in 2026
The AHA will host its inaugural Healthier Together Conference May 12-14, 2026, in Dallas.
AHA podcast: Workforce Culture is the Key to Patient Outcomes
Nell Buhlman, chief administrative officer and head of strategy at Press Ganey, and Chris DeRienzo, M.D., AHA chief physician executive, explore the data-backed connection between employee engagement and patient outcomes.
New AHA, Vizient report shows better outcomes for hospitalized surgical patients
Patients in the hospital for surgeries had better outcomes in 2024 than they did in 2019, according to a
Study finds increase in colorectal cancer detection among people aged 45-49
A JAMA study published yesterday found that more adults age 45-49 have been diagnosed with colorectal canc
AHA defends HHS decision to reject 340B rebate models by drug companies
The AHA today filed an amicus brief in the U.S.
Report: Nearly 57% of new mothers did not attend postpartum follow-up visits
Nearly 57% of mothers did not attend a postpartum follow-up visit three to eight weeks after giving birth, according to a report published July 29 by Cedar Gate Technologies.
FDA issues most serious recall for certain ventilators
The Food and Drug Administration has identified a Class I recall of Philips Respironics V30, A30 and A40 ventilators due to the potential for serious injury or death.